Sign in
CompletedNo phase

Optimal Antibiotics for Operated Diabetic Foot Infections

Key facts

Who runs it
Balgrist University Hospital
Where
Switzerland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
643 people enrolled
Started
4 Sept 2019
Ended
1 Mar 2025
Type of study
Interventional, 8 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Antibiotic therapy
Record updated
17 June 2025

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Diabetic foot infections or ischemia/necrosis with surgical amputation/disarticulation level in vicinity of MRI signs of infection
  • At least two months of follow-up from hospitalization
  • Patient signing to participate, including acceptance of local wound care, -off-loading and arterial re-vascularization (if clinically indicated)

Who cannot take part

  • Any concomitant infection requiring more than 5 days of systemic antibiotic therapy
  • At least 5 cm of distance between amputation level and infection
  • Eventual osteosynthesis material not removed

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Diabetic foot problems, especially infections (DFI), require multiple resources including iterative surgeries and amputations, long-lasting antibiotic therapies, education, off-loading and eventually revascularization and appropriate foot-ware. Treatment is complicated, multidisciplinary, and marked with a high risk of recurrences.

Read full original descriptionShow less

This is a retrospective and prospective cohort with side studies of pathologies and academic research questions that cannot be separated from each other.

The investigators establish a retro-and prospective cohort of diabetic foot problems (ambulatory and hospitalized patients) and perform side studies to reduce the incidence of complications, and to reduce recurrences of DFI, cost and adverse events related to therapies.

Cohort: Prospective and retrospective cohort of all diabetic foot problems with emphasis on surgical and infectious variables.

Trial 1 (Randomized trial on residual infection after amputation):

Determination of the level of amputation per MRI followed by a randomization concerning the duration of post-amputation systemic antibiotic therapy, if there is residual bone infection.

Trial 2 (Randomized trial on infection without amputation):

Determination of the duration of systemic antibiotic therapy in diabetic foot infections without Amputation of the infection.

The 8 groups in the trial

  • 1. Trial (Amputation) Soft tissue - short antibiotic armTreatment being tested

    The intervention group consists of 1 day of postoperative antibiotic therapy for eventual residual soft tissue infection after amputation.

    Treatment: Antibiotic therapy

  • 1. Trial (Amputation) Soft tissue - long antibiotic armExisting treatment, for comparison

    The control group consists of 4 days duration of postoperative antibiotic therapy for eventual residual soft tissue infection after amputation.

    Treatment: Antibiotic therapy

  • 1. Trial (Amputation) Bone - short antibiotic armTreatment being tested

    The intervention group consists of 1 week of postoperative antibiotic therapy for eventual residual bone infection / contamination in the proximal bone stump after amputation.

    Treatment: Antibiotic therapy

  • 1. Trial (Amputation) Bone - long antibiotic armExisting treatment, for comparison

    The intervention group consists of 3 weeks of postoperative antibiotic therapy for eventual residual bone infection / contamination in the proximal bone stump after amputation.

    Treatment: Antibiotic therapy

  • 2.Trial (soft tissue infection) - short antibiotic armTreatment being tested

    The intervention group consists of 10 days of post-debridement antibiotic therapy for non-amputated diabetic foot soft tissue infection.

    Treatment: Antibiotic therapy

  • 2. Trial (soft tissue infection) - long antibiotic armExisting treatment, for comparison

    The control group consists of 20 days of post-debridement antibiotic therapy for non-amputated diabetic foot soft tissue infection.

    Treatment: Antibiotic therapy

  • 2. Trial (osteomyelitis) - short antibiotic armTreatment being tested

    The intervention group consists of 3 weeks of post-debridement antibiotic therapy for non-amputated diabetic foot osteomyelitis.

    Treatment: Antibiotic therapy

  • 2. Trial (osteomyelitis) - long antibiotic armExisting treatment, for comparison

    The control group consists of 6 weeks of post-debridement antibiotic therapy for non-amputated diabetic foot osteomyelitis.

    Treatment: Antibiotic therapy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Optimization of the Surgical and Medical Management of Diabetic Foot Infections
Publications
Record updated
17 June 2025